Alpha 1-antitrypsin (alpha 1AT) deficiency resulting from homozygous inheritance of the Z-type alpha 1AT gene is associated with serum alpha 1AT levels of less than 50 mg/dl and the development of emphysema in the third to fourth decades. Despite the overwhelming evidence that the emphysema of PiZZ individuals develops because of a "deficiency" of alpha 1AT and hence an insufficient antineutrophil elastase defense of the lung, epidemiologic evidence has shown that levels of alpha 1AT of only 80 mg/dl protect the lung from an increased risk of emphysema. With this background, we hypothesized that homozygous inheritance of the Z-type may confer an added risk beyond a simple deficiency of alpha 1AT by virtue of an inability of the Z-type alpha 1AT molecule to inhibit neutrophil elastase as effectively as the common M1-type molecule. To evaluate this hypothesis, the functional status of alpha 1AT from PiZZ individuals (n = 10) was compared with that of alpha 1AT from PiM1M1 individuals (n = 7) for its ability to inhibit neutrophil elastase (percent inhibition) as well as its association rate constant for neutrophil elastase (K association). Plasma alpha 1AT concentration, measured by radial immunodiffusion, was 34 +/- 1 mg/dl in PiZZ patients vs. 237 +/- 14 mg/dl for PiM1M1 plasma, a sevenfold difference. When titrated against neutrophil elastase, the present inhibition of PiZZ plasma was significantly less than Pi M1M1 plasma (ZZ 78 +/- 1% vs. M1M1 95 +/- 1%, P less than 0.001) as was purified Z type alpha 1AT (ZZ, 63 +/- 2% vs. M1M1 86 +/- 2%, P less than 0.001). Sodium dodecyl sulfate (SDS) gel comparisons of the complexes formed with M1-type alpha 1AT and Z-type alpha 1AT with elastase demonstrated the Z alpha 1AT-elastase complexes were less stable than the M1 alpha 1AT-elastase complexes, thus releasing some of the enzyme to continue to function as a protease. Consistent with these observations, the K association of purified Z-type alpha 1AT for neutrophil elastase was lower than that of M1-type alpha 1AT (ZZ 4.5 +/- 0.3 X 10(6) M-1s-1 vs. M1M1 9.7 +/- 0.4 X 10(6) M-1s-1, P less than 0.001), suggesting that for the population of alpha 1AT molecules, the active Z-type molecules take more than twice as long as the active M1-type alpha 1AT to inhibit neutrophil elastase. Consequently, not only is there less alpha1AT in PiZZ individuals, but the population of Z-type alpha1AT molecules is less competent as an inhibitor of neutrophil elastase than M1-type alpha1AT molecules. This combination of defects suggests that PiZZ individuals have far less functional antielastase protection than suggested by the reduced concentrations of alpha1AT alone, further explaining their profound risk for development of emphysema.
F Ogushi, G A Fells, R C Hubbard, S D Straus, R G Crystal
Title and authors | Publication | Year |
---|---|---|
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicine
Fromme M, Klebingat F, Ellis P, Strnad P |
Hepatology Communications | 2025 |
Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity.
McElvaney OJ, Hagstrom J, Foreman MG, McElvaney NG |
American journal of respiratory and critical care medicine | 2024 |
A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency
Chen CH, Crisford H, Scott A, Sapey E, Stockley RA |
Frontiers in pharmacology | 2024 |
Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
Feitosa PH, Castellano MV, da Costa CH, Cardoso AD, Pereira LF, Fernandes FL, Costa FM, Felisbino MB, de Oliveira AF, Jardim JR, Miravitlles M |
Jornal Brasileiro de Pneumologia | 2024 |
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences.
Perez-Luz S, Matamala N, Gomez-Mariano G, Janciauskiene S, Martínez-Delgado B |
Biomedicines | 2023 |
Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain.
Cuenca I, Botella C, Moya-Quiles MR, Jimenez-Coll V, Galian JA, Martinez-Banaclocha H, Muro-Pérez M, Minguela A, Legaz I, Muro M |
2023 | |
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
McElvaney OJ, Cleary B, Fraughen DD, Kelly G, McElvaney OF, Murphy MP, Branagan P, Gunaratnam C, Carroll TP, Goss CH, McElvaney NG |
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation | 2023 |
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
M OBrien, G Murray, D Gogoi, A Yusuf, C McCarthy, M Wormald, M Casey, C Gabillard-Lefort, N McElvaney, E Reeves |
International journal of molecular sciences | 2022 |
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE).
Parsopoulou F, Loules G, Zamanakou M, Csuka D, Szilagyi A, Kompoti M, Porebski G, Psarros F, Magerl M, Valerieva A, Staevska M, Obtulowicz K, Maurer M, Speletas M, Farkas H, Germenis AE |
2022 | |
Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
Buck E, Presotto MA, Brock J, Schlamp K, Veith M, Herth FJ, Trudzinski FC |
Respiratory Medicine Case Reports | 2022 |
Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth.
Tiensuu H, Haapalainen AM, Tissarinen P, Pasanen A, Määttä TA, Huusko JM, Ohlmeier S, Bergmann U, Ojaniemi M, Muglia LJ, Hallman M, Rämet M |
BMC Medicine | 2022 |
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.
Miravitlles M, Herepath M, Priyendu A, Sharma S, Vilchez T, Vit O, Haensel M, Lepage V, Gens H, Greulich T |
European respiratory review : an official journal of the European Respiratory Society | 2022 |
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
OJ McElvaney, GF Curley, S Rose-John, NG McElvaney |
The lancet. Respiratory medicine | 2021 |
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
SS Park, RR Ortega, CW Agudelo, JP Perez, BP Gandara, I Garcia-Arcos, C McCarthy, P Geraghty |
Medicina | 2021 |
Protein Aggregation in the ER: Calm behind the Storm
H Li, S Sun |
Cells | 2021 |
Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease
A Hakim, M Moll, D Qiao, J Liu, JA LaskySu, EK Silverman, S Vilarinho, ZG Jiang, BD Hobbs, MH Cho |
Hepatology Communications | 2021 |
Clinical Cases in Hepatology
NV Bergasa |
2021 | |
Improving Screening for Alpha-1 Antitrypsin Deficiency with Direct Testing in the Pulmonary Function Testing Laboratory
S Gurevich, A Daya, CD Silva, C Girard, F Rahaghi |
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation | 2021 |
High-resolution ex vivo NMR spectroscopy of human Z α1-antitrypsin
AM Jagger, CA Waudby, JA Irving, J Christodoulou, DA Lomas |
Nature Communications | 2020 |
α 1 Antitrypsin therapy modulates the neutrophil membrane proteome and secretome
MP Murphy, T McEnery, K McQuillan, OF McElvaney, OJ McElvaney, S Landers, O Coleman, A Bussayajirapong, P Hawkins, M Henry, P Meleady, EP Reeves, NG McElvaney |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2020 |
Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency
OF McElvaney, MP Murphy, EP Reeves, NG McElvaney |
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation | 2020 |
Dépistage du déficit en alpha1-antitrypsine sur sang capillaire recueilli sur papier-filtre : bilan des 20 premiers mois
CC Cellier, C Narjoz, F Zerimech, MF Odou, P Joly, C Lombard, JF Mornex, M Balduyck |
Revue des Maladies Respiratoires | 2020 |
Clinical manifestations in patients with PI*MM Malton genotypes. A matter still unsolved in alpha‐1 antitrypsin deficiency
M Aiello, A Fantin, C Longo, I Ferrarotti, G Bertorelli, A Chetta |
Respirology Case Reports | 2020 |
Aggregation of M3 (E376D) variant of alpha1- antitrypsin
A Bashir, Y Hazari, D Pal, D Maity, S Bashir, LR Singh, NN Shah, KM Fazili |
Scientific Reports | 2020 |
Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity
EP Reeves, DM Dunlea, K McQuillan, CA ODwyer, TP Carroll, R Saldova, PR Akepati, MR Wormald, OJ McElvaney, V Shutchaidat, M Henry, P Meleady, J Keenan, DC Liberti, DN Kotton, PM Rudd, AA Wilson, NG McElvaney |
Journal of immunology (Baltimore, Md. : 1950) | 2019 |
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
CP Nader, A Cidem, NM Verrills, AJ Ammit |
Respiratory Research | 2019 |
Lectin Complement Pathway in Emphysema
KA Serban, A Mikosz, C Strange, SM Janciauskiene, J Stolk, D Jonigk, RA Sandhaus, I Petrache |
American journal of respiratory and critical care medicine | 2019 |
A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants
R Eggenschwiler, A Patronov, J Hegermann, M Fráguas-Eggenschwiler, G Wu, L Cortnumme, M Ochs, I Antes, T Cantz |
Scientific Reports | 2019 |
Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
AP Lopes, MA Mineiro, F Costa, J Gomes, C Santos, C Antunes, D Maia, R Melo, M Canotilho, E Magalhães, I Vicente, C Valente, BG Gonçalves, B Conde, C Guimarães, C Sousa, J Amado, ME Brandão, M Sucena, MJ Oliveira, S Seixas, V Teixeira, L Telo |
2018 | |
Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation
P Ochieng, S Nath, R Macarulay, E Eden, A Dabo, M Campos, XC Jiang, RF Foronjy, P Geraghty |
Scientific Reports | 2018 |
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency
E Giacopuzzi, M Laffranchi, R Berardelli, V Ravasio, I Ferrarotti, B Gooptu, G Borsani, A Fra |
Human Mutation | 2018 |
Paucimannose-Rich N -glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions
I Loke, O Østergaard, NH Heegaard, NH Packer, M Thaysen-Andersen |
Molecular & cellular proteomics : MCP | 2017 |
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions
YM Hazari, A Bashir, M Habib, S Bashir, H Habib, MA Qasim, NN Shah, E Haq, J Teckmane, KM Fazili |
Mutation Research/Reviews in Mutation Research | 2017 |
Paucimannose-Rich N -glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions
I Loke, O Østergaard, NH Heegaard, NH Packer, M Thaysen-Andersen |
Molecular & cellular proteomics : MCP | 2017 |
Alpha-1 Antitrypsin and Lung Cell Apoptosis
Karina A Serban, Irina Petrache |
Annals of the American Thoracic Society | 2016 |
Molecular Mechanism of Z α1-Antitrypsin Deficiency
X Huang, Y Zheng, F Zhang, Z Wei, Y Wang, RW Carrell, RJ Read, GQ Chen, A Zhou |
The Journal of biological chemistry | 2016 |
Alpha-1 Antitrypsin
A Wanner, RA Sandhaus |
2016 | |
Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells
AD Lockett, DN Petrusca, MJ Justice, C Poirier, KA Serban, NI Rush, M Kamocka, D Predescu, S Predescu, I Petrache |
American journal of physiology. Lung cellular and molecular physiology | 2015 |
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency
EE Cummings, LP OReilly, DE King, RM Silverman, MT Miedel, CJ Luke, DH Perlmutter, GA Silverman, SC Pak, R Aldabe |
PloS one | 2015 |
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema
AN Franciosi, C McCarthy, NG McElvaney |
Expert Review of Respiratory Medicine | 2015 |
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B 4 Neutrophil Signaling
CA ODwyer, ME OBrien, MR Wormald, MM White, N Banville, K Hurley, C McCarthy, NG McElvaney, EP Reeves |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization
V Berthelier, JB Harris, KN Estenson, J Baudry, P Carloni |
PloS one | 2015 |
Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles
LJ Donato, RM Karras, JA Katzmann, DL Murray, MR Snyder |
Respiratory Research | 2015 |
A single-chain variable fragment intrabody prevents intracellular polymerization of Z 1-antitrypsin while allowing its antiproteinase activity
A Ordonez, J Perez, L Tan, JA Dickens, N Motamedi-Shad, JA Irving, I Haq, U Ekeowa, SJ Marciniak, E Miranda, DA Lomas |
The FASEB Journal | 2015 |
Deficiency Mutations of α 1 -antitrypsin Differentially Affect Folding, Function and Polymerization
I Haq, JA Irving, AD Saleh, L Dron, GL Regan-Mochrie, N Motamedi-Shad, JR Hurst, B Gooptu, DA Lomas |
American journal of respiratory cell and molecular biology | 2015 |
The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote
NJ Sinden, F Koura, RA Stockley |
BMC Pulmonary Medicine | 2014 |
α-1-Antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease
NJ Sinden, MJ Baker, DJ Smith, JU Kreft, TR Dafforn, RA Stockley |
American journal of physiology. Lung cellular and molecular physiology | 2014 |
Le déficit en alpha-1-antitrypsine
M Bouchecareilh |
médecine/sciences | 2014 |
α 1 -Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
P Geraghty, E Eden, M Pillai, M Campos, NG McElvaney, RF Foronjy |
American journal of respiratory and critical care medicine | 2014 |
Oxidant-mediated Aggregation of Z α 1 -Antitrypsin in Pulmonary Epithelial Cells Amplifies Lung Inflammation
I Blanco |
American journal of respiratory and critical care medicine | 2014 |
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
L Pini, L Tiberio, N Venkatesan, M Bezzi, L Corda, M Luisetti, I Ferrarotti, M Malerba, DA Lomas, S Janciauskiene, E Vizzardi, D Modina, L Schiaffonati, C Tantucci |
Respiratory Research | 2014 |
Phase I/II Study of Intrapleural Administration of a Serotype rh.10 Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human α1-Antitrypsin cDNA to Individuals with α1-Antitrypsin Deficiency
MJ Chiuchiolo, SM Kaminsky, D Sondhi, D Mancenido, C Hollmann, RG Crystal |
Human Gene Therapy Clinical Development | 2014 |
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio |
Emery and Rimoin's Principles and Practice of Medical Genetics | 2013 |
Recent advances in α-1-antitrypsin deficiency-related lung disease
JA Brebner, RA Stockley |
Expert Review of Respiratory Medicine | 2013 |
Identification and characterization of α 1 -antitrypsin in fibrin clots
S Talens, JJ Malfliet, PT van Hal, FW Leebeek, DC Rijken |
Journal of Thrombosis and Haemostasis | 2013 |
α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment
RA Stockley, AM Turner |
Trends in Molecular Medicine | 2013 |
A Monoclonal Antibody (MCPR3-7) Interfering with the Activity of Proteinase 3 by an Allosteric Mechanism
LC Hinkofer, SA Seidel, B Korkmaz, F Silva, AM Hummel, D Braun, DE Jenne, U Specks |
The Journal of biological chemistry | 2013 |
α1-Antitrypsin Phenotypes and Associated Serum Protein Concentrations in a Large Clinical Population
JA Bornhorst, DN Greene, ER Ashwood, DG Grenache |
Chest | 2013 |
Diseases of the Liver in Children
KF Murray, S Horslen |
2013 | |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Small Molecules That Target Protein Misfolding
LK Gavrin, RA Denny, E Saiah |
Journal of Medicinal Chemistry | 2012 |
Age related development of respiratory abnormalities in non-index α-1 antitrypsin deficient studies
J Holme, JA Stockley, RA Stockley |
Respiratory Medicine | 2012 |
Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency
M Bouchecareilh, DM Hutt, P Szajner, TR Flotte, WE Balch |
The Journal of biological chemistry | 2012 |
Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment
I Kass, AS Knaupp, SP Bottomley, AM Buckle |
Biophysical Journal | 2012 |
How the Serpin α 1 -Proteinase Inhibitor Folds
K Dolmer, PG Gettins |
The Journal of biological chemistry | 2012 |
Alpha-1 antitrypsin deficiency
E Kelly, CM Greene, TP Carroll, NG McElvaney, SJ O’Neill |
Respiratory Medicine CME | 2011 |
Structural Change in β-Sheet A of Z α1-Antitrypsin Is Responsible for Accelerated Polymerization and Disease
AS Knaupp, SP Bottomley |
Journal of Molecular Biology | 2011 |
Alpha-1 Antitrypsin Deficiency
DH Perlmutter |
Schiff s Diseases of the Liver Schiff/Schiff s Diseases of the Liver | 2011 |
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
JA Dickens, DA Lomas |
Drug design, development and therapy | 2011 |
Schiff's Diseases of the Liver: Schiff/Schiff's Diseases of the Liver
H Malhi, GJ Gores |
Schiff's Diseases of the Liver: Schiff/Schiff's Diseases of the Liver | 2011 |
Alpha-1-Antitrypsin Deficiency in Early Childhood
A Topic, D Prokic, I Stankovic |
Fetal & Pediatric Pathology | 2011 |
Alpha-1 antitrypsin deficiency
E Kelly, CM Greene, TP Carroll, NG McElvaney, SJ O'Neill |
Respiratory Medicine | 2010 |
Protein Misfolding Diseases
P Chakrabarty, P Das, TE Golde |
Protein Misfolding Diseases | 2010 |
α;1-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts
IC Sørheim, P Bakke, A Gulsvik, SG Pillai, A Johannessen, PI Gaarder, EJ Campbell, A Agustí, PM Calverley, CF Donner, BJ Make, SI Rennard, J Vestbo, EF Wouters, PD Paré, RD Levy, HO Coxson, DA Lomas, CP Hersh, EK Silverman |
Chest | 2010 |
Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies
AR Tonelli, ML Brantly |
Therapeutic advances in respiratory disease | 2010 |
Molecular Pathology of Liver Diseases
SP Monga |
2010 | |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Molecular Basis of Pulmonary Disease
Farver CF, Zander DS |
Molecular Pathology | 2009 |
Expression, purification and characterization of recombinant Z α1-Antitrypsin—The most common cause of α1-Antitrypsin deficiency
V Levina, W Dai, AS Knaupp, D Kaiserman, MC Pearce, LD Cabrita, PI Bird, SP Bottomley |
Protein Expression and Purification | 2009 |
Molecular Pathology
WB Coleman, GJ Tsongalis |
Molecular Pathology | 2009 |
Basic Concepts of Molecular Pathology
TC Allen, PT Cagle |
2009 | |
Endotoxin receptor CD14 in PiZ α-1-antitrypsin deficiency individuals
CS Sandström, N Novoradovskaya, CM Cilio, E Piitulainen, T Sveger, S Janciauskiene |
Respiratory Research | 2008 |
Alpha-1 Antitrypsin Deficiency: Pathogenesis, Clinical Presentation, Diagnosis, and Treatment
T Köhnlein, T Welte |
The American Journal of Medicine | 2008 |
Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
AA Camelier, DH Winter, JR Jardim, CE Barboza, A Cukier, M Miravitlles |
Jornal Brasileiro de Pneumologia | 2008 |
Molecular Pathology of Lung Diseases
DS Zander, HH Popper, J Jagirdar, AK Haque, PT Cagle, R Barrios |
2008 | |
Molecular diagnostics of α1-antitrypsin deficiency
MP Kaczor, M Sanak, A Szczeklik |
Expert Opinion on Medical Diagnostics | 2007 |
Molecular diagnostics of α 1 -antitrypsin deficiency
MP Kaczor, M Sanak, A Szczeklik |
Expert Opinion on Medical Diagnostics | 2007 |
Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease
DA Lomas |
Proceedings of the American Thoracic Society | 2006 |
Diagnosis of α-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping
MR Snyder, JA Katzmann, ML Butz, P Yang, DB Dawson, KC Halling, WE Highsmith, SN Thibodeau |
Clinical chemistry | 2006 |
Polymers of Z α1-Antitrypsin Co-Localize with Neutrophils in Emphysematous Alveoli and Are Chemotactic in Vivo
R Mahadeva, C Atkinson, Z Li, S Stewart, S Janciauskiene, DG Kelley, J Parmar, R Pitman, SD Shapiro, DA Lomas |
The American Journal of Pathology | 2005 |
SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase
M Gorrini, A Lupi, P Iadarola, CD Santos, P Rognoni, D Dalzoppo, N Carrabino, E Pozzi, A Baritussio, M Luisetti |
Respiratory Research | 2005 |
α1-antitrypsin deficiency
JK Stoller, LS Aboussouan |
The Lancet | 2005 |
Lung Biology in Health and Disease: Cellular and Molecular Mechanisms
E Sapey, R Stockley |
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential | 2005 |
Respiratory Genetics
K Tantisira, J Drazen |
Respiratory Genetics | 2005 |
Comparison of the properties of rare variants of α1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease
S Ray, TD Mickleborough, JL Brown |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2005 |
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology
DA Lomas, H Parfrey |
Thorax | 2004 |
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk
DL DeMeo, EK Silverman |
Thorax | 2004 |
Z α1-Antitrypsin Polymerizes in the Lung and Acts as a Neutrophil Chemoattractant
AT Mulgrew, CC Taggart, MW Lawless, CM Greene, ML Brantly, SJ O'Neill, NG McElvaney |
Chest | 2004 |
Augmentation Therapy for ??1-Antitrypsin Deficiency:
GS Juvelekian, JK Stoller |
Drugs | 2004 |
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies
DC Crowther, D Belorgey, E Miranda, KJ Kinghorn, LK Sharp, DA Lomas |
European Journal of Human Genetics | 2003 |
Alpha-1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy
David Lomas |
Journal of Clinical Investigation | 2002 |
Polyethylene Glycol Conjugation at Cys 232 Prolongs the Half-Life of α 1 Proteinase Inhibitor
AM Cantin, DE Woods, D Cloutier, EK Dufour, R Leduc |
American journal of respiratory cell and molecular biology | 2002 |
The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation
A Elssner, C Vogelmeier |
Transplant Infectious Disease | 2001 |
Therapeutic Elastase Inhibition by Alpha-1-Antitrypsin Gene Transfer Limits Neointima Formation in Normal Rabbits
JM Waugh, J Li-Hawkins, E Yuksel, PN Cifra, PG Amabile, PR Hilfiker, RS Geske, MD Kuo, JW Thomas, MD Dake, SL Woo |
Journal of Vascular and Interventional Radiology | 2001 |
Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency
JA Burrows, LK Willis, DH Perlmutter |
Proceedings of the National Academy of Sciences | 2000 |
LIVER INJURY IN ALPHA1-ANTITRYPSIN DEFICIENCY
DH Perlmutter |
Clinics in Liver Disease | 2000 |
Glucosidase and Mannosidase Inhibitors Mediate Increased Secretion of Mutant α1 Antitrypsin Z
NY Marcus, DH Perlmutter |
The Journal of biological chemistry | 2000 |
Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiency
EJ Campbell, MA Campbell, SS Boukedes, CA Owen |
Journal of Clinical Investigation | 1999 |
Serine proteinase inhibitor therapy in ?1-antitrypsin inhibitor deficiency and cystic fibrosis
G D�ring |
Pediatric Pulmonology | 1999 |
Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiency
EJ Campbell, MA Campbell, SS Boukedes, CA Owen |
Journal of Clinical Investigation | 1999 |
Bronchiolitis Obliterans Syndrome after (Heart–)Lung Transplantation: Impaired Antiprotease Defense and Increased Oxidant Activity
J Hirsch, A Elssner, G Mazur, KL Maier, I Bittmann, J Behr, M Schwaiblmair, H Reichenspurner, H Fürst, J Briegel, C Vogelmeier |
American journal of respiratory and critical care medicine | 1999 |
Molecular Biology of the Lung
RA Stockley |
1999 | |
Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency
N Novoradovskaya, J Lee, ZX Yu, VJ Ferrans, M Brantly |
Journal of Clinical Investigation | 1998 |
A possible association of alpha1-antitrypsin deficiency with the periodontal condition in adults
SJ Fokkema, MF Timmerman, FA Weijden, GN Wolffe, HH Renggli |
Journal of Clinical Periodontology | 1998 |
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema
R Mahadeva, DA Lomas |
Thorax | 1998 |
Thein VitroEffect of Lithocholic Acid on the Polymerization Properties of PiZ Alpha-1-Antitrypsin
MC Gerbod, S Janciauskiene, JO Jeppsson, S Eriksson |
Archives of Biochemistry and Biophysics | 1998 |
Chronic Obstructive Pulmonary Disease (COPD)
Robert M., NR Anthonisen |
American journal of respiratory and critical care medicine | 1998 |
Pulmonary Cell Biology
RJ Mason, RG Crystal |
American journal of respiratory and critical care medicine | 1998 |
Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors
DR Ralston, CB Marsh, MP Lowe, MD Wewers |
Journal of Clinical Investigation | 1997 |
The proteinase-antiproteinase theory of emphysema: A speculative analysis of recent advances into the pathogenesis of emphysema
KR KNIGHT, JG BURDON, L COOK, S BRENTON, M AYAD, ED JANUS |
Respirology | 1997 |
Molecular Basis, Clinical Consequences and Diagnosis of Alpha-1 Antitrypsin Deficiency
MR Norman, AP Mowat, DC Hutchison |
Annals of Clinical Biochemistry | 1997 |
Elastase inhibitory capacity of purified canine alpha-1-antitrypsin
M Vatne, M Andersson, E Sevelius, L Jönsson |
Journal of Comparative Pathology | 1996 |
Kinetic characterisation of ALPHA-1-Antitrypsin F as an inhibitor of human neutrophil elastase
L Cook, JG Burdon, S Brenton, KR Knight, ED Janus |
Pathology | 1996 |
Bioengineering: α1-Proteinase Inhibitor Site-Specific Mutagenesis
M Luisetti, J Travis |
Chest | 1996 |
Use of Secretory Leukoprotease Inhibitor to Augment Lung Antineutrophil Elastase Activity
C Vogelmeier, A Gillissen, R Buhl |
Chest | 1996 |
Alpha-1-antitrypsin PLowell: a normally functioning variant present in low concentration
L Cook, J Burdon, S Brenton, ED Janus, K Knight |
Australian and New Zealand Journal of Medicine | 1995 |
Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease
J Teckman, DH Perlmutter |
Gastroenterology | 1995 |
The Z type variation of human α1-antitrypsin causes a protein folding defect
MH Yu, KN Lee, J Kim |
Nature Structural Biology | 1995 |
α 1 -Antitrypsin Mmalton (Phe 52 -deleted) Forms Loop-Sheet Polymers in Vivo .: EVIDENCE FOR THE C SHEET MECHANISM OF POLYMERIZATION
DA Lomas, PR Elliott, SK Sidhar, RC Foreman, JT Finch, DW Cox, JC Whisstock, RW Carrell |
The Journal of biological chemistry | 1995 |
CLINICAL MANIFESTATIONS OF ALPHA1-ANTITRYPSIN DEFICIENCY
DH Perlmutter |
Gastroenterology Clinics of North America | 1995 |
Letters to the editor
M Erta?, C Ertekin, H Efendi, H Uysal, AA Eisen, RZ Kern, E Chroni, CP Panayiotopoulos, C I�tiguez, H Escobar, A Jimenez-Escrig, KL McKinley, Y Harati, Y Campos, J Esteban, A Cabello, J Arenas, NS Chu, CC Huang, YH Wei, I Ozaki, M Baba, M Ogawa, M Matsunaga, DM Simpson, M Tagliati, M Tanaka, M Bruyland, W Lissens, MD Waele, C Demanet, MT Palmisani, A Evoli, AP Batocchi, E Bartoccioni, P Tonali, EJ Fredericks, LE Bello, L Hagenfeldt, U D�ubeln, G Solders, L Kaijser, JF Jabre, P Mancias, JM Slopis, JW Yeakley, FJ Vriesendorp |
Muscle & Nerve | 1994 |
Alpha1-antitrypsin: molecular structure and the Pi system
G Massi, C Chiarelli |
Acta Paediatrica | 1994 |
Pathogenesis of liver disease in alpha1-antitrypsin deficiency
A Nemeth |
Acta Paediatrica | 1994 |
Vitamin E and liver damage in MZ heterozygous infants with alpha1-antitrypsin deficiency
K Pittschieler |
Acta Paediatrica | 1993 |
Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic Fibrosis
NG McElvaney, B Doujaiji, MJ Moan, MR Burnham, MC Wu, RG Crystal |
American journal of respiratory and critical care medicine | 1993 |
Elevation of Plasma Truncated Elastase α1-Proteinase Inhibitor Complexes in Patients with Inflammatory Lung Diseases
J Fujita, H Nakamura, Y Yamagishi, Y Yamaji, T Shiotani, S Irino |
Chest | 1992 |
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor
C Vogelmeier, RC Hubbard, GA Fells, HP Schnebli, RC Thompson, H Fritz, RG Crystal |
Journal of Clinical Investigation | 1991 |
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages
RC Hubbard, G Fells, J Gadek, S Pacholok, J Humes, RG Crystal |
Journal of Clinical Investigation | 1991 |
The cellular basis for liver injury in α1-antitrypsin deficiency
DH Perlmutter |
Hepatology | 1991 |
Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes
ML Brantly, JT Wittes, CF Vogelmeier, RC Hubbard, GA Fells, RG Crystal |
Chest | 1991 |
Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors
AA McCracken, KB Kruse, J Valentine, C Roberts, TZ Yohannes, JL Brown |
The Journal of biological chemistry | 1991 |
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy
RG Crystal |
Journal of Clinical Investigation | 1990 |
Strategies for aerosol therapy ofα 1-antitrypsin deficiency by the aerosol route
RC Hubbard, RG Crystal |
Lung | 1990 |
Biosynthesis and Secretion of M- and Z-Type α1-Proteinase Inhibitor by Human Monocytes. Effect of Inhibitors of Glycosylation and of Oligosaccharide Processing on Secretion and Function
V GROSS, DV BERG, J KREUZKAMP, U GANTER, J BAUER, G WÜRTEMBERGER, C SCHULZ-HUOTARI, H BEESER, W GEROK |
Biological Chemistry Hoppe-Seyler | 1990 |
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
DT Curiel, C Vogelmeier, RC Hubbard, LE Stier, RG Crystal |
Molecular and cellular biology | 1990 |
α1-Antitrypsin Wbethesda: Molecular basis of an unusual α1-antitrypsin deficiency variant
MD Holmes, ML Brantly, GA Fells, RG Crystal |
Biochemical and Biophysical Research Communications | 1990 |
Comparative properties of human α-1-proteinase inhibitor glycosylation variants
A Guzdek, J Potempa, A Dubin, J Travis |
FEBS Letters | 1990 |
Expression of PiM-and PiZ-mutated forms of the human alpha 1-antitrypsin gene in transfected monkey COS1 cells
ES Davis, N Harpaz, EM Johnson |
The Journal of biological chemistry | 1990 |
Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP
KS Graham, A Le, RN Sifers |
The Journal of biological chemistry | 1990 |
Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance
RC Hubbard, MA Casolaro, M Mitchell, SE Sellers, F Arabia, MA Matthay, RG Crystal |
Proceedings of the National Academy of Sciences | 1989 |
Characterization of the Sequence of the Normal Alpha-1-antitrypsin M3 Allele and Function of the M3 Protein
D Curiel, V Laubach, C Vogelmeier, L Wurts, RG Crystal |
American journal of respiratory cell and molecular biology | 1989 |
The Alpha1-antitrypsin Gene and Its Mutations
RG Crystal, ML Brantly, RC Hubbard, DT Curiel, DJ States, MD Holmes |
Chest | 1989 |
Molecular Basis of the Liver and Lung Disease Associated with the α1-Antitrypsin Deficiency Allele Mmalton
DT Curiel, MD Holmes, H Okayama, ML Brantly, C Vogelmeier, WD Travis, LE Stier, WH Perks, RG Crystal |
The Journal of biological chemistry | 1989 |
Disruption of the 290–342 salt bridge is not responsible for the secretory defect of the PiZ α1-antitrypsin variant
RN Sifers, CP Hardick, SL Woo |
The Journal of biological chemistry | 1989 |
A Pro → Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen
MH Hofker, T Nukiwa, HM van Paassen, M Nelen, JA Kramps, EC Klasen, RR Frants, RG Crystal |
Human Genetics | 1989 |
Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity
J Kleniewski, V Donaldson |
Journal of Experimental Medicine | 1988 |
Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele
T Nukiwa, ML Brantly, F Ogushi, GA Fells, RG Crystal |
The American Journal of Human Genetics | 1988 |
Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency
RC Hubbard, RG Crystal |
The American Journal of Medicine | 1988 |
Molecular basis of alpha-1-antitrypsin deficiency
M Brantly, T Nukiwa, RG Crystal |
The American Journal of Medicine | 1988 |
Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida
H Takahashi, T Nukiwa, K Satoh, F Ogushi, M Brantly, G Fells, L Stier, M Courtney, RG Crystal |
The Journal of biological chemistry | 1988 |